Salzmann Peter

Immunovant, Inc. · Chief Executive Officer

Salzmann Peter is listed in filings as Chief Executive Officer at Immunovant, Inc.. This profile follows SEC Form 4 activity through Apr 17, 2025, including sale activity. Recent filings connect the profile to Immunovant, Inc. (IMVT). The current snapshot covers public activity from Jul 10, 2024 to Apr 17, 2025. Reported amounts are shown as $129.6K to $242.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
Immunovant, Inc.IMVT$130k4.6k sharesSellJul 9, 2024$28.06$38.96
Immunovant, Inc.IMVT$16k510 sharesSellJul 17, 2024$30.55$38.96
Immunovant, Inc.IMVT$242k8.2k sharesSellJul 17, 2024$29.64$38.96
Immunovant, Inc.IMVT$19k598 sharesSellAug 21, 2024$32.32$38.96
Immunovant, Inc.IMVT$461k14.5k sharesSellAug 21, 2024$31.84$38.96
Immunovant, Inc.IMVT$132k4.5k sharesSellOct 9, 2024$29.56$38.96
Immunovant, Inc.IMVT$262k9.1k sharesSellOct 16, 2024$28.79$38.96
Immunovant, Inc.IMVT$425k16.7k sharesSellNov 20, 2024$25.45$38.96
Immunovant, Inc.IMVT$123k5.1k sharesSellJan 8, 2025$24.10$38.96
Immunovant, Inc.IMVT$10k415 sharesSellJan 15, 2025$24.19$38.96
Immunovant, Inc.IMVT$199k8.4k sharesSellJan 15, 2025$23.81$38.96
Immunovant, Inc.IMVT$322k15.4k sharesSellFeb 19, 2025$20.86$38.96
Immunovant, Inc.IMVT$365k28.1k sharesSellApr 9, 2025$12.99$38.96